Enovix Corp Dossier
|
SectorIndustrials IndustryElectrical Equipment & Parts Beta (adjusted)1.89 Intrinsic Value Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet. Market Price $2.78Price as of 1 Oct 2026 Data confidenceNot applicable Market Cap $610.1M Enterprise Value $1.1B Shares Outstanding 221.5M diluted Next Earnings Date27 Oct 2026 All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary Enovix Corp is transitioning from a pre-revenue technology developer to a commercial-scale manufacturer of advanced silicon-anode lithium-ion batteries. The company's proprietary 3D cell architecture addresses the physical swelling challenges of 100% active silicon, offering up to 30% higher energy density than conventional graphite-anode cells. While near-term execution risks remain centered on the qualification and ramp of its Fab2 facility in Malaysia, Enovix's strong liquidity position ($582.7 million in cash and investments) and early commercial traction in defense, wearables, and smartphone qualification frameworks (such as with Honor) support a highly favorable risk-reward profile for growth-oriented investors. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Street view · analyst 12-month targets Low · most bearish analyst$5.50 Mean target$12.25 High · most bullish analyst$25.00 Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario $5.50 Equipment qualification or installation delays at Fab2 push first customer shipments into 2027. Smartphone OEMs delay adoption due to prolonged qualification cycles or alternative battery chemistries. Elevated cash burn forces Enovix to raise additional capital under unfavorable terms, diluting existing shareholders. Base CaseCentral scenario $12.25 Matches the consensus meanEnovix successfully achieves first customer shipments from Fab2 in Malaysia during H2 2026, followed by a gradual production ramp through 2027. Early revenue is driven by defense, industrial, and smart eyewear applications, while smartphone OEM qualifications progress steadily. The company maintains a solid cash runway into late 2027, avoiding near-term dilutive financing. Bull CaseUpside scenario $25.00 Fab2 in Malaysia ramps ahead of schedule with high yields, leading to rapid commercialization. Enovix secures multi-year, high-volume binding supply agreements with multiple tier-1 smartphone OEMs (including Honor) and premium consumer electronics brands. The company achieves operating profitability by late 2027, driven by premium pricing and optimized unit economics. Scenarios are anchored to street consensus at the research date, with our probabilities and rationale. Key Investment Merits
Key Investment Risks
Thesis Invalidation Triggers
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |